These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 9567358)

  • 1. Mechanisms of action of the bisphosphonates.
    Fleisch H
    Medicina (B Aires); 1997; 57 Suppl 1():65-75. PubMed ID: 9567358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental basis for the use of bisphosphonates in Paget's disease of bone.
    Fleisch H
    Clin Orthop Relat Res; 1987 Apr; (217):72-8. PubMed ID: 3549097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates: preclinical aspects and use in osteoporosis.
    Fleisch HA
    Ann Med; 1997 Feb; 29(1):55-62. PubMed ID: 9073324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates: the first 40 years.
    Russell RG
    Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
    Väänänen K
    Adv Drug Deliv Rev; 2005 May; 57(7):959-71. PubMed ID: 15876398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bisphosphonates: pharmacology and use in the treatment of osteoporosis].
    Kishimoto H
    Nihon Rinsho; 1998 Jun; 56(6):1531-6. PubMed ID: 9648477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bisphosphonates: the molecular targets and mechanisms of action].
    Wada S; Kamiya S; Ono K
    Clin Calcium; 2005 May; 15(5):819-24. PubMed ID: 15876745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials with bisphosphonates.
    Lombardi A; Santora AC
    Ann Ital Med Int; 1992; 7(3 Suppl):158S-165S. PubMed ID: 1297394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effects of bisphosphonates in involutional osteoporosis.
    Ott SM
    J Bone Miner Res; 1993 Dec; 8 Suppl 2():S597-606. PubMed ID: 8122531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298.
    Coxon FP; Helfrich MH; Van't Hof R; Sebti S; Ralston SH; Hamilton A; Rogers MJ
    J Bone Miner Res; 2000 Aug; 15(8):1467-76. PubMed ID: 10934645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bisphosphonates in the treatment of multiple myeloma].
    Stajszczyk M
    Przegl Lek; 2002; 59(1):37-42. PubMed ID: 12108045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate therapeutics in bone disease: the hard and soft data on osteoclast inhibition.
    Drake MT; Cremers SC
    Mol Interv; 2010 Jun; 10(3):141-52. PubMed ID: 20539033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates--history and experimental basis.
    Fleisch H
    Bone; 1987; 8 Suppl 1():S23-8. PubMed ID: 3318890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo.
    Hughes DE; Wright KR; Uy HL; Sasaki A; Yoneda T; Roodman GD; Mundy GR; Boyce BF
    J Bone Miner Res; 1995 Oct; 10(10):1478-87. PubMed ID: 8686503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates: mechanisms of action and clinical use in osteoporosis--an update.
    Fleisch H
    Horm Metab Res; 1997 Mar; 29(3):145-50. PubMed ID: 9137986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effects of bisphosphonates.
    Green JR
    Cancer; 2003 Feb; 97(3 Suppl):840-7. PubMed ID: 12548584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bisphosphonate therapy in osteoporosis. Inhibition of trabecular perforation by aminobisphosphonate].
    Wüster C; Heilmann P
    Fortschr Med; 1997 Oct; 115(29):37-42. PubMed ID: 9445833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates: mode of action and pharmacology.
    Russell RG
    Pediatrics; 2007 Mar; 119 Suppl 2():S150-62. PubMed ID: 17332236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation of the pro-apoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts/osteocytes with novel analogs.
    Plotkin LI; Manolagas SC; Bellido T
    Bone; 2006 Sep; 39(3):443-52. PubMed ID: 16627025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of bisphosphonates on growth of amoebae of the cellular slime mold Dictyostelium discoideum.
    Rogers MJ; Watts DJ; Russell RG; Ji X; Xiong X; Blackburn GM; Bayless AV; Ebetino FH
    J Bone Miner Res; 1994 Jul; 9(7):1029-39. PubMed ID: 7942149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.